Results 121 to 130 of about 5,892 (166)

The PKD Daily: Development and Content Validation of a Hybrid Diary for Tracking Urinary Events in Adults with Autosomal Dominant Polycystic Kidney Disease (ADPKD). [PDF]

Adv Ther
O'Connor M, Broderick L, Waldman LT, Costa E, Carty M, Nunna S, Oberdhan D.   +6 more
europepmc   +1 more source

SGLT2 Inhibitors in Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Tantush A, Ben Hamida B, Sagher M, Afsheen N, Sager M, Abusbaeh A, Tantoush M, Abusbaeh A, Najaim A, Alhamadi M, Hesham Gamal M, Alemam MM, Elhady MM.   +12 more
europepmc   +1 more source

Long-Term Exposure to Fine Particulate Matter and Kidney Function among Patients with Polycystic Kidney Disease. [PDF]

Clin J Am Soc Nephrol
Kwag Y, Min J, Lee W, Ahn S, Kim S, Ha H, Kim MH, Oh J, Kang DH, Ha E.   +9 more
europepmc   +1 more source

Nephrogenic Syndrome of Inappropriate Antidiuresis: Case Report and Genetic Perspectives. [PDF]

Nephrology (Carlton)
Chen XJ, Kou M, Feng M, Wang LH, Wei JJ.
europepmc   +1 more source

Refractory hyponatremia in small cell lung cancer: a case report and literature review. [PDF]

Front Endocrinol (Lausanne)
Bao S, Qin L, Zhang Y, Jiang X, Duan L.
europepmc   +1 more source

Real-World Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Therapy in Nondiabetic Autosomal-Dominant Polycystic Kidney Disease: Effects on Progression to Dialysis in a TrinetX Cohort. [PDF]

Mayo Clin Proc Innov Qual Outcomes
Chang CH, Kuo YC, Kuan YH, Lim PS, Chung MC, Pan YR, Luo CW, Wu TK.   +7 more
europepmc   +1 more source

Personalized Sequential Nephron Blockade for Diuretic Resistance in Acute Decompensated Heart Failure: A Narrative Review for the Cardiorenal Clinician. [PDF]

J Pers Med
Gembillo G, Sessa C, Zanoli L, Visconti L, Ricca MF, Lo Cicero L, Corsonello A, Petrina S, Nicosia A, Soraci L, Fede G, Piccione G, Lumera S, Morale W, Santoro D.   +14 more
europepmc   +1 more source

PaO₂/FiO₂ Ratio As an Exploratory Indicator of Oxygenation Changes in Acute Decompensated Heart Failure Treated with Intravenous Tolvaptan. [PDF]

CJC Open
Hoya H, Gatate Y, Matsuo K, Nomoto M, Arai T, Nakano S.   +5 more
europepmc   +1 more source

Advances in the Treatment of Autosomal Dominant Polycystic Kidney Disease and Novel Therapeutic Targets. [PDF]

Curr Issues Mol Biol
Zhang W, Sun T, Wang X, Jiang T.
europepmc   +1 more source

Short-Term Effects of Pecavaptan on Weight and Congestion in Acute Heart Failure: The AVANTI Post-Hoc Analysis. [PDF]

JACC Adv
Ceelen DCH, Voordes GHD, Cosic L, Ter Maaten JM, Goldsmith SR, Burkhoff D, Gustafsson F, Frost R, Duarte K, Monzo L, Girerd N, Zannad F, Udelson JE, Voors AA.   +13 more
europepmc   +1 more source